Ultrahigh resolution lipid mass spectrometry imaging of high-grade serous ovarian cancer mouse models

dc.contributor.authorMa, Xin
dc.contributor.authorBotros, Andro
dc.contributor.authorYun, Sylvia R.
dc.contributor.authorPark, Eun Young
dc.contributor.authorKim, Olga
dc.contributor.authorPark, Soojin
dc.contributor.authorPham, Thu-Huyen
dc.contributor.authorChen, Ruihong
dc.contributor.authorPalaniappan, Murugesan
dc.contributor.authorMatzuk, Martin M.
dc.contributor.authorKim, Jaeyeon
dc.contributor.authorFernández, Facundo M.
dc.contributor.departmentBiochemistry and Molecular Biology, School of Medicine
dc.date.accessioned2024-04-11T11:53:07Z
dc.date.available2024-04-11T11:53:07Z
dc.date.issued2024-01-08
dc.description.abstractNo effective screening tools for ovarian cancer (OC) exist, making it one of the deadliest cancers among women. Considering that little is known about the detailed progression and metastasis mechanism of OC at a molecular level, it is crucial to gain more insights into how metabolic and signaling alterations accompany its development. Herein, we present a comprehensive study using ultra-high-resolution Fourier transform ion cyclotron resonance matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MSI) to investigate the spatial distribution and alterations of lipids in ovarian tissues collected from double knockout (n = 4) and triple mutant mouse models (n = 4) of high-grade serous ovarian cancer (HGSOC). Lipids belonging to a total of 15 different classes were annotated and their abundance changes were compared to those in healthy mouse reproductive tissue (n = 4), mapping onto major lipid pathways involved in OC progression. From intermediate-stage OC to advanced HGSC, we provide direct visualization of lipid distributions and their biological links to inflammatory response, cellular stress, cell proliferation, and other processes. We also show the ability to distinguish tumors at different stages from healthy tissues via a number of highly specific lipid biomarkers, providing targets for future panels that could be useful in diagnosis.
dc.eprint.versionFinal published version
dc.identifier.citationMa X, Botros A, Yun SR, et al. Ultrahigh resolution lipid mass spectrometry imaging of high-grade serous ovarian cancer mouse models. Front Chem. 2024;11:1332816. Published 2024 Jan 8. doi:10.3389/fchem.2023.1332816
dc.identifier.urihttps://hdl.handle.net/1805/39907
dc.language.isoen_US
dc.publisherFrontiers Media
dc.relation.isversionof10.3389/fchem.2023.1332816
dc.relation.journalFrontiers in Chemistry
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourcePMC
dc.subjectMass spectrometry imaging
dc.subjectMatrix-assisted laser desorption/ionization
dc.subjectHigh-grade serous ovarian cancer
dc.subjectLipidomics
dc.subjectBiomarkers mass spectrometry imaging
dc.subjectBiomarkers
dc.titleUltrahigh resolution lipid mass spectrometry imaging of high-grade serous ovarian cancer mouse models
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
fchem-11-1332816.pdf
Size:
3.54 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: